FDA: Johnson & Johnson COVID-19 vaccine tied to Guillain-Barré syndrome

FDA: Johnson & Johnson COVID-19 vaccine tied to Guillain-Barré syndrome

The FDA has said that Johnson & Johnson’s COVID-19 vaccine may lead to an increased risk for Guillain-Barré syndrome.The New York Times reported on July 12 that officials identified 100 suspected cases of Guillain-Barré syndrome, a neurological condition in which the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis, that were…

Obesity links to increased risk for Crohn’s disease

Obesity links to increased risk for Crohn’s disease

Obesity correlated with an increased risk for older-age onset Crohn’s disease but not ulcerative colitis, according to research published in Clinical Gastroenterology and Hepatology.“As a major environmental factor in the development of autoimmune diseases, obesity may contribute substantially to the etiopathogenesis of inflammatory bowel disease, particularly in those with older-onset IBD, where relative to those…

Malnutrition persistent in patients with COVID-19 at 3- and 6-months post-infection

Malnutrition persistent in patients with COVID-19 at 3- and 6-months post-infection

For patients with COVID-19, at 3- and 6-months, malnutrition was the most persistent gastrointestinal sequalae, according to a study published in Clinical Gastroenterology and Hepatology.“It’s overall reassuring that most GI symptoms, for patients who presented with severe COVID-19, resolve within 3 to 6 months,” Arvind Trindade, MD, FASGE, director of endoscopy, Long Island Jewish Medical…